Although some details are still murky, a first-blush analysis of Obama Administration’s fiscal year 2011 budget doesn’t look good for US efforts to combat the HIV and tuberculosis epidemics. From treatment to prevention, these global health threats could get short-changed under the White House plan. Let’s start with PEPFAR, the President’s Emergency Plan for AIDS Relief. […]
New results from a tuberculosis vaccine trial indicate that the Mycobacterium vaccae (MV) was effective in preventing TB among people with HIV. Given that TB is the No. 1 killer of people with HIV in the developing world, this could be a major advance in the battle against these synergistic scourges. In the seven-year study […]
HIV
Amid unprecedented challenges to routine healthcare access, trial results mark a first for a critically needed HIV prevention measure An investigational drug administered by injection every […]
Tuberculosis
In the six weeks before South Africa responded its first diagnoses of COVID-19 with the start of physical distancing measures, more than 47,000 people on average […]
Research & Development
What we have learned from HIV can guide responses to COVID-19 that are innovative, effective and inclusive, and can help end the pandemic faster The following […]
Policy
The following is a guest post by Kenneth G. Castro, MD, FIDSA Since its formation in 1948, WHO has relied heavily on the U.S. for collaborations […]